203 related articles for article (PubMed ID: 21093499)
1. Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6.
Baker N; Alsford S; Horn D
Mol Biochem Parasitol; 2011 Mar; 176(1):55-7. PubMed ID: 21093499
[TBL] [Abstract][Full Text] [Related]
2. Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei.
Wyllie S; Foth BJ; Kelner A; Sokolova AY; Berriman M; Fairlamb AH
J Antimicrob Chemother; 2016 Mar; 71(3):625-34. PubMed ID: 26581221
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters.
Schumann Burkard G; Jutzi P; Roditi I
Mol Biochem Parasitol; 2011 Jan; 175(1):91-4. PubMed ID: 20851719
[TBL] [Abstract][Full Text] [Related]
4. A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes.
Wilkinson SR; Taylor MC; Horn D; Kelly JM; Cheeseman I
Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5022-7. PubMed ID: 18367671
[TBL] [Abstract][Full Text] [Related]
5. A molecular mechanism for eflornithine resistance in African trypanosomes.
Vincent IM; Creek D; Watson DG; Kamleh MA; Woods DJ; Wong PE; Burchmore RJ; Barrett MP
PLoS Pathog; 2010 Nov; 6(11):e1001204. PubMed ID: 21124824
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance in human African trypanosomiasis.
Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma brucei eflornithine transporter AAT6 is a low-affinity low-selective transporter for neutral amino acids.
Mathieu C; González Salgado A; Wirdnam C; Meier S; Grotemeyer MS; Inbar E; Mäser P; Zilberstein D; Sigel E; Bütikofer P; Rentsch D
Biochem J; 2014 Oct; 463(1):9-18. PubMed ID: 24988048
[TBL] [Abstract][Full Text] [Related]
8. High-throughput decoding of antitrypanosomal drug efficacy and resistance.
Alsford S; Eckert S; Baker N; Glover L; Sanchez-Flores A; Leung KF; Turner DJ; Field MC; Berriman M; Horn D
Nature; 2012 Jan; 482(7384):232-6. PubMed ID: 22278056
[TBL] [Abstract][Full Text] [Related]
9. Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis.
Sokolova AY; Wyllie S; Patterson S; Oza SL; Read KD; Fairlamb AH
Antimicrob Agents Chemother; 2010 Jul; 54(7):2893-900. PubMed ID: 20439607
[TBL] [Abstract][Full Text] [Related]
10. Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs.
Hall BS; Meredith EL; Wilkinson SR
Antimicrob Agents Chemother; 2012 Nov; 56(11):5821-30. PubMed ID: 22948871
[TBL] [Abstract][Full Text] [Related]
11. Forward Genetics in African Trypanosomes.
Hutchinson S; Glover L
Methods Mol Biol; 2020; 2116():339-352. PubMed ID: 32221930
[TBL] [Abstract][Full Text] [Related]
12. Evaluating 5-nitrofurans as trypanocidal agents.
Bot C; Hall BS; Alvarez G; Di Maio R; González M; Cerecetto H; Wilkinson SR
Antimicrob Agents Chemother; 2013 Apr; 57(4):1638-47. PubMed ID: 23335745
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the Trypanosoma brucei superoxide dismutase gene sodb1 increases sensitivity to nifurtimox and benznidazole.
Prathalingham SR; Wilkinson SR; Horn D; Kelly JM
Antimicrob Agents Chemother; 2007 Feb; 51(2):755-8. PubMed ID: 17145786
[TBL] [Abstract][Full Text] [Related]
14. Genetic dissection of drug resistance in trypanosomes.
Alsford S; Kelly JM; Baker N; Horn D
Parasitology; 2013 Oct; 140(12):1478-91. PubMed ID: 23552488
[TBL] [Abstract][Full Text] [Related]
15. Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives.
Wilkinson SR; Bot C; Kelly JM; Hall BS
Curr Top Med Chem; 2011; 11(16):2072-84. PubMed ID: 21619510
[TBL] [Abstract][Full Text] [Related]
16. Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei.
Vincent IM; Creek DJ; Burgess K; Woods DJ; Burchmore RJ; Barrett MP
PLoS Negl Trop Dis; 2012; 6(5):e1618. PubMed ID: 22563508
[TBL] [Abstract][Full Text] [Related]
17. Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites.
Hall BS; Bot C; Wilkinson SR
J Biol Chem; 2011 Apr; 286(15):13088-95. PubMed ID: 21345801
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review and Meta-Analysis on Human African Trypanocide Resistance.
Kasozi KI; MacLeod ET; Welburn SC
Pathogens; 2022 Sep; 11(10):. PubMed ID: 36297157
[TBL] [Abstract][Full Text] [Related]
19. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model.
Dauchy FA; Bonhivers M; Landrein N; Dacheux D; Courtois P; Lauruol F; Daulouède S; Vincendeau P; Robinson DR
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005125. PubMed ID: 27855164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
